Postantibiotic, postantibiotic sub-MIC, and subinhibitory effects of PGE-9509924, ciprofloxacin, and levofloxacin

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 10, 2003, Pages 3352-3356

  Odenholt, Inga ^a,b   Löwdin, Elisabeth ^a   Cars, Otto ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CIPROFLOXACIN; LEVOFLOXACIN; OFLOXACIN; PGE 9509924; QUINOLONE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL STRAIN; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; ESCHERICHIA COLI; GENETICS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; KLEBSIELLA PNEUMONIAE; MICROBIOLOGICAL EXAMINATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POSTANTIBIOTIC EFFECT; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; OFLOXACIN; PSEUDOMONAS AERUGINOSA; QUINOLONES; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

EID: 0141924815     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.10.3352-3356.2003     Document Type: Article

References (21)

1. Boswell, F. J., J. M. Andrews, and R. Wise. 1997. Postantibiotic effect of trovafloxacin on Pseudomonas aeruginosa. J. Antimicrob. Chemother. 39: 811-814.
2. Cars, O., and I. Odenholt-Tornqvist. 1993. The postantibiotic sub-MIC effect (PA SME) in vitro and in vivo. J. Antimicrob. Chemother. 31(Suppl. D):159-166.
3. Craig, W. A., and S. Gudmundsson. 1996. The postantibiotic effect, p. 296-329. In V. Lorian (ed.), Antibiotics in laboratory medicine, 4th ed. Williams & Wilkins Co., Baltimore, Md.
4. Craig, W. A. 1998. Pharmacokinetic/pharmacodynamic parameters: the rationale for antibacterial dosing in mice and men. Clin. Infect. Dis. 26:1-12.
5. Craig, W. A. 1998. Choosing an antibiotic on the basis of pharmacodynamics. Ear Nose Throat J. 77:7-12.
6. Craig, W. A. 2001. Does the dose matter? Clin. Infect. Dis. 33(Suppl. 3): 233-237.
7. Jones, M. E., I. A. Critchley, J. A. Karlowsky, R. S. Blosser-Middleton, F.-J. Schmitz, C. Thornsberry, and D. F. Sahm. 2002. In vitro activities of novel nonfluorinated quinolones PGE 9262932 and PGE 9509924 against clinical isolates of Staphylococcus aureus and Streptococcus pneumoniae with defined mutations in DNA gyrase and topoisomerase IV. Antimicrob. Agents Chemother. 46:1651-1657.
8. Licata, L., C. E. Smith, R. M. Goldschimidt, J. F. Barrett, and M. Frosco. 1997. Comparison of the postantibiotic and postantibiotic sub-MIC effects of levofloxacin and ciprofloxacin on Staphylococcus aureus and Streptococcus pneumoniae. Antimicrob. Agents Chemother. 41:950-955.
9. Löwdin, E., I. Odenholt, S. Bengtsson, and O. Cars. 1993. A new method to determine postantibiotic effect and the effects of subinhibitory antibiotic concentrations. Antimicrob. Agents Chemother. 37:2200-2205.
10. McCloskey, L., T. Moore, N. Niconovich, B. Donald, J. Broskey, C. Jakielaszek, S. Rittenhouse, and K. Coleman. 2000. In vitro activity of gemifloxacin against a broad range of recent clinical isolates from the USA J. Antimicrob. Chemother. 45(Suppl. S1):13-21.
11. National Committee for Clinical Laboratory Standards. 1992. Methods for determining bactericidal activity of antimicrobial agents. Tentative guideline M26-T. National Committee for Clinical Laboratory Standards, Villanova, Pa.
12. Odenholt, I., S.-E. Holm, and O. Cars. 1990. Effects of supra- and sub-MIC benzylpenicillin concentrations on group A beta-hemolytic streptococci during the postantibiotic phase in vivo. J. Antimicrob. Chemother. 26:193-201.
13. Odenholt, I., E. Löwdin, and O. Cars. 1991. Pharmacodynamic effects of subinhibitory concentrations of β-lactam antibiotics in vitro. Antimicrob. Agents Chemother. 35:1834-1839.
14. Odenholt, I., E. Löwdin, and O. Cars. 1992. Postantibiotic sub-MIC effects of vancomycin, roxithromycin, sparfloxacin, and amikacin. Antimicrob. Agents Chemother. 36:1852-1858.
15. Odenholt, I., and S. Bengtsson. 1994. Postantibiotic-effect and postantibiotic effect of subinhibitory concentrations of sparfloxacin on gram-negative bacteria. Chemotherapy 40:30-36.
16. Odenholt, I., E. Löwdin, and O. Cars. 1997. Comparative in vitro pharmacodynamics of BO-2727, meropenem and imipenem against gram-positive and gram-negative bacteria. Clin. Microbiol. Infect. 3:73-81.
17. Odenholt, I., E. Löwdin, and O. Cars. 1998. In vitro pharmacodynamic studies of L 749-345 against gram-positive and gram-negative bacteria. Antimicrob. Agents Chemother. 42:2365-2370.
18. Odenholt, I., E. Löwdin, and O. Cars. 2000. Pharmacodynamic studies of trovafloxacin and grepafloxacin against gram-positive and gram-negative bacteria. J. Antimicrob. Chemother. 46:35-43.
19. Odenholt-Tornqvist, I. 1993. The postantibiotic effect and the postantibiotic sub-MIC effect of meropenem measured with two different methods. J. Antimicrob. Chemother. 31:881-892.
20. Pankuch, G. A., M. R. Jacobs, and P. C. Appelbaum. 1998. Postantibiotic effect of trovafloxacin against gram-positive and -negative organisms. Antimicrob. Agents Chemother. 42:1503-1505.
21. Spangler, S. K., S. Bajaksouzian, M. R. Jacobs, and P. C. Appelbaum. 2000. Postantibiotic effects of grepafloxacin compared to those of five other agents against 12 gram-positive and -negative bacteria. Antimicrob. Agents Chemother. 44:186-189.